OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc.

    VANCOUVER, British Columbia, Oct. 28 /CNW/ -- ProtoKinetix Inc. (OTC
Bulletin Board: PKTX), a biotech company focused on the research, development
and commercialization of patented anti-aging glycopeptides (AAGPs(TM)),
announced today that OTC Financial Network (OTCFN), a division of National
Financial Communications Corp. (NFC), has issued a corporate profile on the
Company. The OTCFN Report includes details on the ProtoKinetix technology
platform, its multiple commercial applications, global target markets and
management team. Interested parties can download the report at

    "Dr. Castelot-Deliencourt, chief scientist for ProtoKinetix, has achieved
what was previously thought to be the impossible. She created a synthetic
version of AFGP (Anti-Freeze Glycoprotein), a naturally occurring compound
that enables cell survival in freezing temperatures. Her lab-created version
is the industry's first stable, non-toxic and bioactive compound, even at low
concentrations. Patented and trademarked by ProtoKinetix as AAGPs(TM), this
revolutionary technology and its derivatives have shown to increase cellular
health, survival and seem to have anti-inflammatory properties," said Geoffrey
Eiten, publisher of the OTCFN Report.

    "This year, ProtoKinetix entered its exciting commercial development
phase, establishing partnerships with skin care manufacturers, and umbilical
cord blood and health care companies to research and develop life-enhancing
applications of AAGP(TM). The Company's goal is to begin generating recurring
licensing revenues and royalty fees in 2009, and to increase shareholder value
over the long-term," concluded Eiten.

    About ProtoKinetix
    ProtoKinetix, Inc. is a biotechnology company that has developed and
patented a family of synthetic anti-aging glycopeptides (AAGP(TM)) for
medicine and the biotechnology and cosmetic industries. PKTX is currently in
dialog with major corporations and institutions who have contacted the Company
about the broad range of applications for AAGP(TM) products. For more
information, visit http://www.protokinetix.com.

    OTC Financial Network serves as special advisor to ProtoKinetix Inc. and
has received fees for services, including two hundred and fifty-thousand
shares of restricted stock, in addition to an option to purchase two-hundred
fifty-thousand shares at an exercise price of twenty cents per share, for the
creation and implementation of an awareness program, including the OTC FN
Report. This is not an offer to buy or sell securities. Information or
opinions in this release are presented solely for informative purposes, and
are not intended nor should they be construed as investment advice. A full
disclaimer can be found online by visiting

    The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. Some information included in this
press release contains statements that are forward-looking. Such
forward-looking information involves significant risks and uncertainties that
could affect anticipated results in the future and, accordingly, these results
may differ materially from those expressed in any forward-looking statements
made by or on behalf of the Company. For a description of additional risks and
uncertainties, please refer to the Company's filings with the Securities and
Exchange Commission.


      At OTC Financial Network:
      Rick McCaffrey, Investor Relations
      781-444-6100 x625

      At ProtoKinetix:
      Blair Henderson
      Email: info@protokinetix.com


For further information:

For further information: Rick McCaffrey, OTC Financial Network,
+1-781-444-6100 ext. 625, rick@otcfn.com; Blair Henderson, ProtoKinetix,
+1-604-687-9887, info@protokinetix.com Web Site: http://www.nationalfc.com   

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890